Negotiations to settle a longstanding case involving annuities owed to 12 First Nations along the shores of Lake Superior have broken down. The Supreme Court of Canada had given the federal and ...

First Nations along Lake Superior in Northern Ontario have turned down a $3.6-billion offer from government officials and say they will ask the Supreme Court to make a better compensation offer ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

But hidden at your pharmacy among the potpourri of cough drops and cold remedies, you can find a low-risk treatment that actually may help: nasal irrigation devices. Several small studies suggest ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment ... trial where Spravato alone demonstrated quick and superior improvement in participants’ Montgomery-Asberg ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Sitting on the shores of Lake Superior surrounded by towering Hemlock trees this cabin gives a true Upper Peninsula experience − and now you can reserve it in advance. The Kaug Wujdoo Modern ...

Superior Plus Propane was formerly known as Salem Propane, and this isn’t the first time multiple customers have said they’re without heat. The same story happened about a year ago.

A nasal rinse is a common practice to clear nasal passages, especially during cold, flu, and allergy seasons. It helps remove mucus, debris, and allergens that build in the nose. “A saltwater rinse is ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...